- Home
- ZVSA vs YCBD Comparison
ZVSA vs YCBD Comparison
Compare ZVSA & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVSA
- YCBD
- Stock Information
- Founded
- ZVSA 2014
- YCBD 2015
- Country
- ZVSA United States
- YCBD United States
- Employees
- ZVSA N/A
- YCBD N/A
- Industry
- ZVSA Biotechnology: Pharmaceutical Preparations
- YCBD Biotechnology: Pharmaceutical Preparations
- Sector
- ZVSA Health Care
- YCBD Health Care
- Exchange
- ZVSA Nasdaq
- YCBD Nasdaq
- Market Cap
- ZVSA 1.5M
- YCBD 1.6M
- IPO Year
- ZVSA N/A
- YCBD N/A
- Fundamental
- Price
- ZVSA $1.42
- YCBD $0.50
- Analyst Decision
- ZVSA Strong Buy
- YCBD
- Analyst Count
- ZVSA 1
- YCBD 0
- Target Price
- ZVSA $240.00
- YCBD N/A
- AVG Volume (30 Days)
- ZVSA 2.2M
- YCBD 3.2M
- Earning Date
- ZVSA 11-14-2024
- YCBD 02-11-2025
- Dividend Yield
- ZVSA N/A
- YCBD N/A
- EPS Growth
- ZVSA N/A
- YCBD N/A
- EPS
- ZVSA N/A
- YCBD N/A
- Revenue
- ZVSA N/A
- YCBD $19,482,167.00
- Revenue This Year
- ZVSA N/A
- YCBD $13.00
- Revenue Next Year
- ZVSA N/A
- YCBD N/A
- P/E Ratio
- ZVSA N/A
- YCBD N/A
- Revenue Growth
- ZVSA N/A
- YCBD N/A
- 52 Week Low
- ZVSA $0.98
- YCBD $0.31
- 52 Week High
- ZVSA $25.00
- YCBD $1.34
- Technical
- Relative Strength Index (RSI)
- ZVSA 57.25
- YCBD 53.41
- Support Level
- ZVSA $1.31
- YCBD $0.42
- Resistance Level
- ZVSA $1.95
- YCBD $0.82
- Average True Range (ATR)
- ZVSA 0.19
- YCBD 0.12
- MACD
- ZVSA 0.04
- YCBD 0.01
- Stochastic Oscillator
- ZVSA 44.21
- YCBD 34.18
About ZVSA ZyVersa Therapeutics Inc.
ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD and hempMD. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.